Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease

被引:14
|
作者
Duan, Xiao Yan [2 ]
Zhao, He Ping [3 ]
Fan, Jian Gao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Xinhua Hosp, Shanghai 200092, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200092, Peoples R China
[3] Shanxi Med Univ, Dept Gen Practice, Hosp 1, Taiyuan, Peoples R China
关键词
fatty liver; non-alcoholic steatohepatitis; oxidative stress; rats; RT-PCR; thioredoxin; OXIDATIVE STRESS; CELLS; OVEREXPRESSION; APOPTOSIS; GENE; STEATOHEPATITIS; THIOACETAMIDE; PROTECTION; SYSTEM; MICE;
D O I
10.1111/j.1751-2980.2010.00422.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: To investigate the expression and significance of thioredoxin messenger ribonucleic acid (mRNA) in the development of non-alcoholic fatty liver disease (NAFLD) induced by a high fat diet. METHODS: A total of 48 male Wistar rats were divided into a normal control group and a model group, which were both divided into three subgroups (at weeks 9, 13 and 18, respectively). The levels of serum tumor necrosis factor-alpha (TNF-alpha), free fatty acid (FFA), total cholesterol (TC) and triglyeride (TG), changes in the serum and hepatic tissue superoxide dismutase (SOD), reduced glutathione hormone (GSH) and malondialdehyde (MDA) were measured. The expression of thioredoxin mRNA in rat livers were detected with reverse transcriptase polymerase chain reaction (RT-PCR). Meanwhile, the pathological changes of liver tissue were observed by hematoxylin-eosin stain. RESULTS: Simple fatty liver was observed in model group at week 9. From weeks 13 to 18, liver histopathology showed steatohepatitis. Compared with corresponding normal groups, in the model groups the levels of TNF-alpha, FFA, TC, TG in serum, and MDA in serum and liver increased significantly, while the vitality of SOD and GSH content in serum and liver decreased remarkably. Meanwhile, in the model group, the expression of hepatic thioredoxin mRNA was significantly decreased at week 9 compared with the normal group (P < 0.01), then increased gradually, but were lower than the corresponding normal groups at all times (P < 0.01). CONCLUSION: The expression of thioredoxin mRNA is significantly lower in the liver of rats with NAFLD and might reach the lowest point after developing simple fatty liver. Meanwhile the downregulation of thioredoxin mRNA may cause the inflammatory injury initially in NAFLD.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [1] Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
    Doecke, S.
    Lock, J. F.
    Birkenfeld, A. L.
    Hoppe, S.
    Lieske, S.
    Rieger, A.
    Raschzok, N.
    Sauer, I. M.
    Florian, S.
    Osterhoff, M. A.
    Heller, R.
    Herrmann, K.
    Lindenmueller, S.
    Horn, P.
    Bauer, M.
    Weickert, M. O.
    Neuhaus, P.
    Stockmann, M.
    Moehlig, M.
    Pfeiffer, A. F. H.
    von Loeffelholz, C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (05) : 547 - 557
  • [2] HEPATIC LUMICAN EXPRESSION IN PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE
    Fitzpatrick, Emer
    Mitry, Ragai R.
    Quaglia, Alberto
    Dhawan, Anil
    HEPATOLOGY, 2010, 52 (04) : 1037A - 1037A
  • [3] Hepatic lipid metabolism and non-alcoholic fatty liver disease
    Tessari, P.
    Coracina, A.
    Cosma, A.
    Tiengo, A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (04) : 291 - 302
  • [4] Hepatic Chemerin is Induced in Non-Alcoholic Fatty Liver Disease
    Buechler, Christa
    Wanninger, Josef
    Bauer, Sabrina
    Eisinger, Kristina
    Schacherer, Doris
    Hellerbrand, Claus
    Weiss, Thomas S.
    Schaffler, Andreas
    DIABETES, 2012, 61 : A691 - A692
  • [5] Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
    Brunt, Elizabeth M.
    Kleiner, David E.
    GUT, 2017, 66 (09) : 1539 - +
  • [6] Hepatic gene expression of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) model rats using DNA microarray analysis
    Ohba, Keiichiro
    Iwai, Shinichi
    Watanabe, Minoru
    Matsumoto, Naoki
    Koizumi, Go
    Oda, Go
    Kumai, Toshio
    Kobayashi, Shinichi
    Oguchi, Katsuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 216P - 216P
  • [7] Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats
    Fisher, Craig D.
    Lickteig, Andrew J.
    Augustine, Lisa M.
    Elferink, Ronald P. J. Oude
    Besselsen, David G.
    Erickson, Robert P.
    Cherrington, Nathan J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 613 (1-3) : 119 - 127
  • [8] Altered hepatic expression of genes regulating lipogenesis in non-alcoholic fatty liver disease
    Morgan, K
    Mao, L
    Morgan, TR
    GASTROENTEROLOGY, 2005, 128 (04) : A703 - A703
  • [9] Experimental models of non-alcoholic fatty liver disease in rats
    Otto Kucera
    Zuzana Cervinkova
    World Journal of Gastroenterology, 2014, (26) : 8364 - 8376
  • [10] Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats
    Korkmaz, Huseyin Anil
    Aktug, Huseyin
    Atila, Dincer
    Barisik, Vatan
    Arslan, Nur
    Erbas, Oytun
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 306 - 306